Results 161 to 170 of about 825,921 (342)
Objective This study aims to develop hip morphology‐based radiographic hip osteoarthritis (RHOA) risk prediction models and investigates the added predictive value of hip morphology measurements and the generalizability to different populations. Methods We combined data from nine prospective cohort studies participating in the Worldwide Collaboration ...
Myrthe A. van den Berg +26 more
wiley +1 more source
Petersen Majken +4 more
doaj +2 more sources
Najmaddin A H Hatem,1 Mohammed A Kubas,2,3 Seena A Yousuf,4 Abdunaser Rassam,5 Mohamed Izham Mohamed Ibrahim6 1Department of Clinical Pharmacy, College of Clinical Pharmacy, Hodeidah University, Al-Hudaydah, Yemen; 2Clinical Pharmacy Department, School ...
Hatem NAH +4 more
doaj
Objective We assessed whether circulating adipokines are associated with incident fractures in patients with rheumatoid arthritis (RA). Methods Three adipokines (adiponectin, leptin, and fibroblast growth factor [FGF]‐21) were measured using banked enrollment serum from participants in a longitudinal RA cohort.
Joshua F. Baker +9 more
wiley +1 more source
Evaluation of clinical pharmacy services in patients receiving antithrombotic treatment in a randomized controlled trial. [PDF]
Sosyal D +3 more
europepmc +1 more source
Clinical Pharmacy Interventions in Pediatric Intensive Care Unit: A Review
Annette Mariam Mathew, Juny Sebastian
openalex +1 more source
Clinical Maturity in Pharmacy [PDF]
openaire +2 more sources
Objective We conducted formative research aimed at identifying solutions that address inequitable health outcomes in lupus due to adverse social determinants of health (SDoH). Methods We conducted a search for keywords, which provided insights into potential solutions and initiatives underway. An advisory panel of lupus experts iteratively reviewed the
Joy Buie +11 more
wiley +1 more source
Impact of Clinical Pharmacy Team Intervention on Naloxone Fills in Patients on ChroCnic Opioid Therapy. [PDF]
Sijapati RS, Himes ER, Hale SA.
europepmc +1 more source

